Almeda Ventures
VC Fund
Tel Aviv, Israel
Almeda Ventures is a VC fund in Tel Aviv focused on Health Care and Medical Device. Almeda Ventures is the first HealthTech focused public R&D partnership. We invest on a global basis while focusing on: Medical devices Digital health Bio-convergenceWe help our portfolio companies to thrive using our team’s deep expertise, diverse background and extensive network with investors, strategics and medical centers worldwide.Almeda Ventures drives medical device and digital health companies for success by utilizing its extensive network and proven track record.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Almeda Ventures invests in
Stages Almeda Ventures invests in
Countries Almeda Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $14M–$14M
- Series D
- $25M–$83M
- Venture - Series Unknown
- $13M–$20M
Investment Focus
Industry
- Health Care 8 (67%)
- Medical Device 4 (33%)
- Machine Learning 3 (25%)
- Fitness 2 (17%)
- Software 2 (17%)
Stage
- Venture - Series Unknown 3 (25%)
- Series A 2 (17%)
- Series D 2 (17%)
- Funding Round 2 (17%)
- Series C 1 (8%)
Country
- Israel 5 (42%)
- United States 3 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Amir Blatt
Founding Partner & CIO
|
Founding Partner & CIO | Total investments: 0 | Find email | |
Idan Nurick
Independent Director
|
Independent Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Augmedics
|
Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures. | $82.5M / Series D / Jun 27, 2023 | |
Sensi.AI
|
Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care | $14M / Series A / Dec 12, 2021 | |
Sensi AI
|
Clanz Technologies offers an audio-based system designed to support security in human interactions. The system works by connecting to devices that record audio. It analyzes audio data to find unusual sounds or patterns that may indicate incidents. When an anomaly is detected, the system sends alerts in real time. The service also providesinformation about conditions that can affect care quality, such as stress levels or lack of training. It can be used in places where monitoring human interaction is important for safety. The company offers a demo for organizations that want to use the system. | $14M / Series A / Dec 12, 2021 | |
FlexDex
|
FlexDex is a minimally invasive surgery medical device technology that provides high dexterity. Its platform technology translates the surgeon’s hand, wrist, and arm movements from outside the patient into corresponding movements of an end-effector inside the patient’s body.The company was founded in 2010 and is headquartered in Brighton,Michigan. | $13M / Venture - Series Unknown / Aug 24, 2021 | |
|
FlexDex
|
FlexDex is a minimally invasive surgery medical device technology that provides high dexterity. Its platform technology translates the surgeon’s hand, wrist, and arm movements from outside the patient into corresponding movements of an end-effector inside the patient’s body.The company was founded in 2010 and is headquartered in Brighton,Michigan. | $13M / Venture - Series Unknown / Aug 24, 2021 | |
TailorMed
|
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $20M / Venture - Series Unknown / Jun 07, 2021 | |
|
Augmedics
|
Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures. | $36M / Series C / Mar 30, 2021 | |
Lumen
|
Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team. | Venture - Series Unknown / Nov 29, 2020 | |
Nurami Medical
|
Nurami Medical is dedicated to the development of a surgical scaffold platform for the repair, regeneration and safe healing of soft tissues following internal surgeries. Nurami Medical production technology is based on the electrospinning technique. | Nov 01, 2020 | |
BioProtect
|
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CEmarked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US. | Oct 07, 2020 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Almeda Ventures invest in?
Almeda Ventures invests primarily in Health Care, Medical Device and Machine Learning startups, most often at Venture - Series Unknown and Series A stage. Most of the 12 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Almeda Ventures's check size?
Almeda Ventures typically joins rounds of $14M–$14M at Series A, $25M–$83M at Series D and $13M–$20M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Almeda Ventures participates in.
How do I contact Almeda Ventures?
Public channels for Almeda Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Almeda Ventures?
The team at Almeda Ventures includes Amir Blatt (Founding Partner & CIO) and Idan Nurick (Independent Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
